Age-related Outcome for Peripheral Thrombolysis

Lambert, Anthony; Trkulja, D; Fox, Andrew; Budd, J. S.; Chalmers, A H; Horrocks, M.

doi:10.1053/ejvs.1998.0722

Cited by 14 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[21] Also, in this context, a previous study showed higher rates of early re-thrombosis and major amputations in younger patients who failed thrombolytic therapy when compared to older patients, which was attributed to the higher smoking rates in younger patients. [22] Furthermore, it is well known that atherosclerosis has such a virulent course with high rates of recurrence or progressive disease which is strikingly associated with cigarette smoking. [23] Cigarette smoking contributes to the recurrence of ischemic events, anti-platelet resistance, and high PAD prevalence by causing a shift in the homeostasis balance toward thrombus formation by causing endothelial injury, plaques formation, plaques rupture, platelet activation, platelet aggregation and platelet adhesion stimulating coagulation cascade.…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical recurrence and antiplatelet drug resistance among patients with lower limb ischemia

Alrabadi,

Aljarrah,

Alzoubi

et al. 2024

Medicine

View full text Add to dashboard Cite

There is a high prevalence rate of peripheral artery disease worldwide, with estimated cases exceeding 200 million. Most patients are under-diagnosed and under-treated, and there is a lack of knowledge regarding the best therapeutic regimen and therapy duration, which leads to many cases of recurrence, complications, and amputations. This study aims to explore clinical recurrence, which was defined as the worsening of chronic peripheral artery disease requiring hospital admission, and its relationship with antiplatelet drug resistance among patients with lower limb ischemia. This cohort study includes both retrospective and prospective recruitment of patients with chronic lower limb ischemia. Platelet aggregation tests were offered to the patients. Between February 2018 and November 2020, 147 patients were recruited from King Abdullah University Hospital and followed up for at least 1 year. Platelet aggregation tests were done for 93 patients who agreed to participate in this part of the study. The prevalence of chronic lower limb ischemia was higher in young male patients who are current smokers with co-morbid diseases such as hypertension, diabetes mellitus, and/or dyslipidemia. There was a significant association only of clinical recurrence with younger age (P = .011) and with low platelets count in severe stages of the disease (P = .047). No significant association was found in terms of laboratory resistance. The clinical recurrence rates of chronic lower limb ischemia were higher in younger patients and among those with low platelet counts in the severe stages of the disease. Despite the laboratory responsiveness to anti-platelet therapy, we observed significant clinical resistance and increased recurrence rates.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%